SCHEMBL4774657

SCHEMBL4774657

Cc1ccc(NC(=O)C(C)C)cc1C1CCN(CCCNC(=O)Cc2ccc(F)cc2)CC1

nearest known ligand 0.77

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
DRD2 P14416 1/20 0.56
ADRA1A P35348 1/20 0.56
CCR3 P51677 3/20 0.47
HTR2A P28223 2/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5510038 0.87 ADRA1D (0.53) ADRA1A
SCHEMBL5516005 0.87 DRD2 (0.53) DRD2ADRA1A
SCHEMBL4766883 0.87 DRD2 (0.53) DRD2ADRA1A
SCHEMBL5660427 0.85 MCHR1 (0.61) DRD2ADRA1A
SCHEMBL4792335 0.85 DRD2 (0.51) DRD2ADRA1A
SCHEMBL5517610 0.85 DRD2 (0.51) DRD2ADRA1A
SCHEMBL5517914 0.84 DRD2 (0.50) DRD2ADRA1A
SCHEMBL5660979 0.82 DRD2 (0.55) DRD2ADRA1AHTR2A
SCHEMBL14546145 0.81 DRD2 (0.51) DRD2ADRA1A
SCHEMBL5515361 0.80

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1590326-A4 SUBSTITUTED ALKYL AMIDO PIPERIDINES LUNDBECK & CO AS H (DK) 2008-04-30 EP disclosed
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-7199135-B2 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2007-04-03 US disclosed
US-20060217418-A1 Substituted alkyl amido piperidines H. LUNDBECK A/S (DK) 2006-09-28 US disclosed
US-20060084649-A9 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION (US) 2006-04-20 US disclosed
EP-1590326-A2 SUBSTITUTED ALKYL AMIDO PIPERIDINES H. Lundbeck A/S (DK) 2005-11-02 EP disclosed
US-20040186103-A1 Substituted alkyl amido piperidines SYNAPTIC PHARMACEUTICAL CORPORATION 2004-09-23 US disclosed
WO-2004064764-A2 SUBSTITUTED ALKYL AMIDO PIPERIDINES H. LUNDBECK A/S (DK) 2004-08-05 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084649-A9 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ADRA1A 54/4885CCR3 485/4885
US-20060217418-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ADRA1A 54/4885CCR3 485/4885
US-20040186103-A1 Substituted alkyl amido piperidines MCHR1, MCHR2, MC1R DRD2 74/4885ADRA1A 54/4885CCR3 485/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.